Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Date limite
30.06.2026
Publié
26.10.2026
Attribué
26.10.2026
Preliminary Market Engagement for Real Time Location System (
Ouvert aux offres·Oct 19
Purchase of lightsouce
Attribué·Oct 16
Purchase of Cardiotocography machines
Attribué·Oct 12
Purchase of ENT Microscopes
Attribué·Oct 7
Rental of 1 x Interventional Radiology Suite
Attribué·Oct 6
Linen & Laundry - Managed Services
Attribué·Sep 29
Histology Reporting
Attribué·Oct 14
WSFT - Pathology - Bloodtrack software support
Attribué·Oct 9
WSFT - Pathology - AlinIQ Indexor
Attribué·Oct 9
WSFT - Pathology - Bloodtrack software support
Attribué·Oct 1
WSFT - Managed Service - Pathology - Microbiology testing Pro-Lab Diagnostics
Attribué·Sep 4
Pathology Managed Service for Midlands & East 2 Network
Attribué·Jul 10
2026-10-28 09:00 - QSB467 Ipswich to Pushforward Secondary (various locations in Ipswich, Stowmarket & Bury St Edmunds) - AWARD
Attribué·Oct 31
March 2027 Bus Contracts
Attribué·Oct 31
Infrastructure Connection Design Support - Pathology Lab
Attribué·Oct 30
Provision of Pre-Paid Cards
Attribué·Oct 30
7.5t Isuzu Repower (Electrification) 7.5t Isuzu with NTM Polybody Refurbishment
Attribué·Oct 30
Business Travel Services
Attribué·Oct 30
Créez un compte pour étudier cet appel d’offres et trouver des opportunités similaires.